Clinical Trials Sponsored by Almirall, SAS

Total 11299 results

Almirall, SAS

Completed

ARTIST: ARThrose Intervention STandardisée (ARTIST)

Knee Osteoarthritis

France
Medical University of Graz
Almirall, SAS

Not yet recruiting

Tirbanibulin 1% Ointment for the Treatment of Actinic Keratosis on the Back of the Hands

Actinic Keratoses
Angela Moore
Almirall, SAS

Completed

Sarecycline Truncal Acne Safety and Efficacy Response (TASER)

Acne Vulgaris

United States
Almirall, S.A.

Recruiting

A Single and Multiple Ascending Dose Study of LAD603 in Healthy Subjects

Healthy Volunteers

United States
Almirall, S.A.

Active, not recruiting

Observational Study of Tildrakizumab in Patients With Moderate to Severe Plaque Psoriasis in Routine Clinical Practice (SAIL)

Plaque Psoriasis

Germany, Austria, Italy, Netherlands
Almirall, S.A.

Active, not recruiting

Observational Real-world Evidence (RWE) Study to Assess Patient-reported Wellbeing Using Tildrakizumab in Live Setting - POSITIVE Study (POSITIVE)

Plaque Psoriasis

Germany
Almirall, S.A.

Completed

UV Sensor in Patients With Actinic Keratosis

Keratosis, Actinic

Spain
Almirall, S.A.

Completed

Efficacy and Safety of Tildrakizumab in Participants With Moderate-to-Severe Chronic Plaque Psoriasis Who Are Non-Responders to Dimethyl Fumarate Therapy (TRANSITION)

Plaque Psoriasis

United Kingdom, Germany
Almirall, S.A.

Completed

Study Evaluating Preference, Satisfaction and Ease of Use of Inhalers in Chronic Obstructive Pulmonary Disease (COPD) Diagnosed Patients

Chronic Obstructive Pulmonary Disease (COPD)

Germany, Netherlands
Almirall, S.A.

Completed

A Single-dose, Randomised, Crossover, Placebo-controlled Study Assessing Two Fixed-dose Combinations of Inhaled Long-acting Beta-agonist and Corticosteroid

Asthma

Germany, United Kingdom
Almirall, S.A.

Completed

Neurophysiological Study of Sativex in Multiple Sclerosis (MS) Spasticity (NS-MSS)

Multiple Sclerosis

Italy
Almirall, S.A.

Completed

Study to Investigate Skin Conditions and Patient Assessment of LAS 41002 in the Treatment of Atopic Eczema

Atopic Eczema

Germany
Almirall, S.A.
Almirall Hermal GmbH

Completed

Study To Evaluate The Efficacy And Safety Of Actikerall® Solution In Patients With Grade I-II Actinic Keratoses

Actinic Keratosis

Germany, United Kingdom
Almirall, S.A.

Not yet recruiting

A Study to Evaluate the Efficacy and Safety of Tirbanibulin Ointment in Adult Participants With Actinic Keratosis

Keratosis, Actinic
Almirall, S.A.

Recruiting

A Study of Tildrakizumab in the Treatment of Genital Psoriasis (CZATCH-Genital-PsO)

Genital Psoriasis

Austria
Almirall, S.A.

Recruiting

A Study to Assess Treatment Satisfaction, Patient-reported Outcomes, Effectiveness, and Safety of a Fixed-dose Combination of Calcipotriene/Betamethasone Dipropionate PAD Cream in the Treatment of Mild-to-moderate Plaque Psoriasis of the Scalp in Adults (PRO-SCALP)

Plaque Psoriasis

Germany, Spain, United Kingdom
Almirall, S.A.

Recruiting

A Study of Tirbanibulin Ointment and Diclofenac Sodium Gel for the Treatment of Adult Participants With Actinic Keratosis on the Face or Scalp

Keratosis, Actinic

Poland, Spain, United Kingdom, France, Germany, Italy
Almirall, S.A.

Active, not recruiting

A Study of Lebrikizumab in Combination With Topical Corticosteroids in Participants Having Atopic Dermatitis (AD) That Are Not Adequately Controlled or Non-eligible for Cyclosporine

Eczema | Dermatitis, Atopic

Austria, Belgium, France, Germany, Netherlands, Poland, Spain, United Kingdom
Almirall, S.A.

Completed

A Study to Evaluate the Safety and Tolerability of Tirbanibulin Ointment 1% in Adult Participants With Actinic Keratosis

Keratosis, Actinic

United States
Almirall, S.A.

Completed

A Study of Tirbanibulin on the Wellbeing of Participants With Actinic Keratoses

Actinic Keratosis

Italy, Spain
Almirall, S.A.

Completed

Patient-reported Outcomes for Sarecycline Effectiveness and Safety (PROSES) (PROSES)

Acne Vulgaris

United States
Almirall, S.A.

Completed

Standardized sTudy With Almotriptan in eaRly Treatment of Migraine (START)

Migraine

France, Italy, Spain
Almirall, S.A.

Completed

Efficacy and Safety Study of LAS41007 in the Treatment of Actinic Keratosis

Actinic Keratosis

Germany
Almirall, S.A.

Completed

Efficacy and Safety of LAS41003 in the Treatment of Inflammatory Tinea Pedis

Tinea Pedis

Germany
Almirall, S.A.

Completed

Efficacy and Safety of LAS41003 in the Treatment of Superficial Infected Eczema

Eczema

Germany
Almirall, S.A.

Recruiting

A Study to Assess the Effects of Switching From a Biologic Treatment to Tildrakizumab Using Patient-reported Outcomes in Adult Participants With Moderate to Severe Plaque Psoriasis

Plaque Psoriasis

Austria
Almirall, S.A.

Recruiting

Effectiveness and Safety of Lebrikizumab Treatment in Adults and Adolescents With Moderate-to-Severe Atopic Dermatitis (ADhope)

Eczema | Atopic Dermatitis

Germany, Netherlands, United Kingdom
Almirall, S.A.

Active, not recruiting

Long-term Safety and Efficacy of Lebrikizumab in Adult and Adolescent Participant With Moderate-to-Severe Atopic Dermatitis (ADlong)

Atopic Dermatitis

Germany, Poland
Almirall, S.A.

Completed

Patient and Clinician Reported Outcomes for Tirbanibulin Effectiveness and Safety in Actinic Keratosis (PROAK)

Keratosis, Actinic

United States
Almirall, S.A.

Completed

Efficacy and Safety of Tildrakizumab 100 Milligrams (mg) in Participants With Moderate-Severe Chronic Plaque Psoriasis and Its Impact on Their Quality of Life (TRIBUTE) (TRIBUTE)

Plaque Psoriasis

Spain, Italy
Almirall, S.A.

Completed

Study of Pidotimod in Children With Recurrent Respiratory Tract Infections (RRI) (P-CRESCENT)

Recurrent Respiratory Tract Infections

China
Almirall, S.A.

Terminated

Long-Term Treatment Effect With Tildrakizumab in Participants With Plaque Psoriasis (MODIFY)

Plaque Psoriasis

Poland
Almirall, S.A.

Completed

Study of the Effects of the Organism on Monomethyl Fumarate (MMF) After the Administration of LAS41008 (LAS41008)

Psoriasis

United Kingdom
Almirall, S.A.

Completed

Study on the Efficacy of LAS41005 in the Treatment of Actinic Keratosis

Actinic Keratosis

Germany
Almirall, S.A.

Completed

Efficacy and Safety of Tazarotene Gel in Nail Psoriasis

Nail Psoriasis

Germany
Almirall, S.A.

Completed

A Intra-individual Comparison to Investigate the Efficacy and the Safety of LAS41004 Formulation in Mild to Moderate Psoriasis (Left/Right)

Psoriasis

Germany
Almirall, S.A.

Completed

Study to Investigate Dose-related Efficacy of LAS41004 in the Treatment of Psoriasis

Psoriasis

Germany
Almirall, S.A.

Completed

Clinical Trial to Investigate Efficacy of LAS41004 in Psoriasis

Psoriasis

Germany
Almirall, S.A.

Completed

LAS41005 in Hyperkeratotic Actinic Keratosis

Actinic Keratosis

Germany
Almirall, S.A.

Completed

Double-blind, Randomized, Vehicle- and Comparator-controlled, Multi-center Trial to Evaluate the Efficacy and Safety of LAS41007 in the Treatment of Actinic Keratosis

Actinic Keratosis

Germany
Almirall, S.A.

Completed

Efficacy and Safety of LAS41003 in the Treatment of Intertriginous Candida Infections

Candidiasis

Germany
Almirall, S.A.
Allergan

Completed

Photoallergy Potential of Dapsone Gel in Healthy Volunteers

Healthy Volunteers

United States
Almirall, S.A.
Allergan

Completed

A Safety and Efficacy Study of Dapsone Gel in Patients With Acne Vulgaris

Acne Vulgaris

United States, Canada
Almirall, S.A.
Allergan

Completed

Phototoxicity Test of Dapsone Gel in Healthy Volunteers

Healthy Volunteers

United States
Almirall, S.A.
Harrison Clinical Research; Almirall Hermal GmbH

Completed

LAS41008 in Moderate to Severe Chronic Plaque Psoriasis

Plaque Psoriasis

Austria, Germany, Netherlands, Poland
Almirall, S.A.
Allergan

Completed

Safety and Efficacy Trial of ACZONE (Dapsone) Gel, 7.5% in 9 to 11 Year-Old Patients With Acne Vulgaris

Acne Vulgaris

United States
Almirall, S.A.
Allergan

Completed

Double-Blind, Placebo-Controlled Study to Evaluate 3 Doses of a Novel Tetracycline in the Treatment of Facial Acne Vulgaris

Acne Vulgaris

United States
Almirall, S.A.
Allergan

Completed

Study to Evaluate Safety & Efficacy of Sarecycline in Treatment of Acne

Acne Vulgaris

United States
Almirall, S.A.
Allergan

Completed

Randomized, Double-blind, Placebo-controlled Study to Evaluate Safety & Efficacy of Sarecycline in Treatment of Acne

Acne Vulgaris

United States
Almirall, S.A.
Allergan

Completed

A Multi-Center Open-Label Evaluation of the Safety of Sarecycline Tablets in the Treatment of Acne Vulgaris

Acne Vulgaris

United States

3

Subscribe